Tag: DRSP
-
YAZ / Yasmin / Ocella: FDA Study Suggests An Increased Risk Of Blood Clots That Can Cause Side Effects Like Pulmonary Embolism
Early Results Suggest An Approximately 1.5-fold Increase In The Risk For Birth Control Pills With Drospirenone (DRSP) (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: YAZ / Yasmin / Ocella Update: October 2011 FDA…
-
YAZ / Yasmin / Ocella / Beyaz / Safyral: Drug Safety Regulators Focus On Blood Clot Side Effects
EMA Orders New Warning About Risk Of Venous Thromboembolism, While FDA And Health Canada Begin Safety Review (Posted by Tom Lamb at DrugInjuryWatch.com) In recent months there has been a flurry of activity by…
-
YAZ And Yasmin MDL: First Trial In Federal Court Set By Judge Herndon To Start September 2011
A Pulmonary Embolism Bellwether Case Will Be Followed By Gallbladder And Venous Thromboembolic Lawsuit Trials (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: The January 9, 2012 Sims v. Bayer "bellwether", or test, trial has been postponed…
-
November 2009 Medical Journal Article Describes Large Ongoing Study About Safety Of YAZ
INAS-OC Study: Intended To Evaluate Risk Of Developing Cardiovascular Side Effects For Women Who Use YAZ (DRSP/EE 24d) (Posted by Tom Lamb at DrugInjuryWatch.com) In May 2009 we first wrote about the International Active…
-
YAZ And Yasmin May Have Higher Risk Of Venous Thrombosis Than Older Birth Control Pills
Recent Studies Find That New Progestin Drospirenone Has 1.7 Times Increased Risk Of Developing Blood Clots Compared To Levonorgestrel (Posted by Tom Lamb at DrugInjuryWatch.com) _________________________________________________________________________________________ UPDATE: "Bayer Affirms Safety Of YAZ / Yasmin…
-
A Theory Of How Yasmin Or YAZ Might Cause Pulmonary Embolism (PE) And Other Blood Clot Related Side Effects
Combination Of Ethinylestradiol And Drospirenone Increases Serum Copper, A Situation That Could Be Associated With Increased Cardiovascular Risk (Posted by Tom Lamb at DrugInjuryWatch.com) In the August 1, 2009 edition of the medical journal…